Cargando…
A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients
OBJECTIVE: This study aimed to compare the historical incidence rate of severe oral mucositis (OM) in head and neck cancer patients undergoing definitive concurrent chemoradiation therapy (CRT) versus a prospective cohort of patients with locally advanced head and neck squamous cell carcinoma (HNSCC...
Autores principales: | Taylor, Janielle K.‐A., Mady, Leila J., Baddour, Khalil, Iheagwara, Uzoma K., Zhai, Shuyan, Ohr, James P., Zandberg, Daniel P., Gorantla, Vikram C., Ferris, Robert L., Kim, Seungwon, Duvvuri, Umamaheswar, Kubik, Mark W., Sridharan, Shaum, Johnson, Jonas T., Holeva, Karen D., Quinn, Annette E., Clump, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714046/ https://www.ncbi.nlm.nih.gov/pubmed/36474663 http://dx.doi.org/10.1002/wjo2.18 |
Ejemplares similares
-
Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis
por: Borson, Steven, et al.
Publicado: (2022) -
Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer
por: Thomas, Joel, et al.
Publicado: (2020) -
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer
por: Bauman, Julie E., et al.
Publicado: (2020) -
Profiling the Stromal and Vascular Heterogeneity in Patient-derived Xenograft Models of Head and Neck Cancer: Impact on Therapeutic Response
por: Folaron, Margaret, et al.
Publicado: (2019) -
Photobiomodulation and Oral Mucositis: A Systematic Review
por: Cronshaw, Mark, et al.
Publicado: (2020)